Follow us...

 

Search News Archives

Monthly Newsletter

Lab Bulletin March Newsletter

 

VIEW THE LATEST ISSUE

SUBSCRIBE Here

News Channels

 

Coronavirus (COVID-19)

New Laboratory Products

Lab News

Research & Case Studies

Microscopy | Image Analysis

Separation Science

Brochures & Literature

Videos

Events | Webinars

 

 

Conferences | Events

Irvine Scientific Introduces PRIME-XV T Cell Culture Medium for Immunotherapy Applications

publication date: Feb 3, 2015
 | 
author/source: Irvine Scientific

Irvine Scientific, a world leader in the innovation and manufacture of cell culture media, announced today the introduction of PRIME-XV® T Cell Expansion XSFM, a xeno-free and serum-free medium.

irvine Scientific logoPRIME-XV T Cell Expansion XSFM is a medium optimized for the expansion of human T cells that reliably maintains potency and is the newest medium in the PRIME-XV cell therapy product line that supports immunotherapy.

Immunotherapy has emerged as a viable approach for treating some forms of cancer. Using a process called adoptive cell transfer (ACT), T cells have been engineered to produce chimeric antigen receptors (CARs), a surface receptor that allows T cells to recognize tumor-specific proteins and subsequently kill the targeted tumor cells. This method has generated positive results in small clinical trials, indicating its potential as a treatment. To further support the research and development into ACT, efficient expansion of desired T cell subsets with proper potency is critical to ensure an adequate population of T cells with targeted specificity.

“Immunotherapy offers significant hope, particularly in the area of novel cancer treatment options,” said Dr. Jessie H.-T. Ni, Chief Scientific Officer at Irvine Scientific. “We have developed this new medium using the most up-to-date knowledge of T cell biology to deliver improved performance over serum-containing and other existing commercial xeno-free, serum-free media in supporting ex vivo quality expansion of various human T cell subsets.”

Irvine Scientific supports immunotherapy with products and services for cancer stem/initiating cell expansion and tumorsphere formation, mesenchymal stem/stromal cell expansion, and a full suite of recombinant human growth factors to supplement any variety of applications. To facilitate clinical applications and scale-up, PRIME-XV T Cell Expansion XSFM is available for custom formulation and packaging.


more about irvine scientific


 

 

 



 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd

 

 

Media Partners